Skip to main content
. Author manuscript; available in PMC: 2019 Feb 20.
Published in final edited form as: AIDS. 2018 Feb 20;32(4):419–429. doi: 10.1097/QAD.0000000000001704

Figure 3. THC treatment decreased the percentage of CD16+, CD163+, CD16+CD163+ and IFNAR+ cells within the monocyte population.

Figure 3

(A–D) PBMCs from HIV-MJ− donors (N=11 for A–C and N=5 for D) and (E–G) purified CD16− monocytes from HIV-MJ− (N=7) and HIV+MJ− (N=7) donors were pretreated with 0 (vehicle), 0.5 (purified only), 1, 5 and 10μM of THC for 0.5h and stimulated with IFNα (50U/ml) for 48h. *Statistically different from vehicle control (50 U/mL IFNα+vehicle) (p<0.05, RM one-way ANOVA with a Dunnett’s multiple comparisons post-test). NS represents vehicle without IFNα addition. Graphs in A–F are mean +/− SEM.